Condensed Balance Sheets - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current assets
Cash	$ 676,564
Prepaid expenses	798,779
Due from Sponsor	25,000
Total Current Assets	1,500,343
Deferred offering costs		89,500
Marketable securities held in Trust Account	230,003,907
TOTAL ASSETS	231,504,250	89,500
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Accounts payable and accrued expenses	81,118
Accrued offering costs	10,532
Income taxes payable
Promissory note – related party		69,500
Total Current Liabilities	91,650	69,500
Warrant liabilities	10,500,000
Deferred underwriting commission payable	8,650,000
Total Liabilities	19,241,650	69,500
Commitments and Contingencies
Class A ordinary shares subject to possible redemption 20,725,908 and no shares at redemption value at March 31, 2021 and December 31, 2020, respectively	207,262,597
Shareholders’ Equity
Preference shares, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 2,274,092 and no shares issued and outstanding (excluding 20,725,908 and no shares subject to possible redemption) at March 31, 2021 and December 31, 2020, respectively	227
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding, at March 31, 2021 and December 31, 2020	575	575
Additional paid-in capital	2,457,671	24,425
Retained earnings (accumulated deficit)	2,541,530	(5,000)
Total Shareholders’ Equity	5,000,003	20,000
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 231,504,250	$ 89,500